OpenVSafe by OpenVAERS
Search V-safe

WXN-21279-92329

1 vaccination 4 coded responses 6 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
928 / CA
Registered
2021-02-02
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-30
    Dose 1 — Moderna
  2. 2021-02-02
    Registered in v-safe
  3. 2021-02-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeding disorder — Feeling: Poor · Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: I can't eat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Vertigo, Weight decreased — Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Severe weight loss, vertigo, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-03
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-02-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Urinary retention — Feeling: Poor · Site: Pain · Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: I can't pee
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-01
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-06-19
  9. 2021-06-23
  10. 2021-07-19
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  11. 2021-07-31
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  12. 2022-01-30
    Survey response — 12 months, dose 1
    MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: See below
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-01-30
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  14. 2022-01-31

Vaccinations

DoseDateManufacturerCo-administered
12021-01-30Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-02-03 Successful
2021-07-19
 Reported to VAERS voluntarily prior to GDIT contact
2022-01-30 Unsuccessful

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-02

Systemic reaction (other): I can't eat

2021-02-03

Systemic reaction (other): Severe weight loss, vertigo, dizziness

2021-02-04

Systemic reaction (other): I can't pee

Release 11 — 12 months, dose 1

2022-01-30

Symptoms: See below

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDUnevaluable event · · ✓
SRODizziness ✓ ✓ ✓
SROFeeding disorder ✓ ✓ ✓
SROUrinary retention ✓ ✓ ✓
SROVertigo ✓ ✓ ✓
SROWeight decreased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…